Pulmonary Vein Isolation for the Treatment of Drug-Refractory Atrial Fibrillation in Adults with Congenital Heart Disease
| Autor: | Femi Philip, Richard A. Krasuski, Kamran I. Muhammad, Shikar Agarwal, Andrea Natale |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Ejection fraction Heart disease business.industry valvular heart disease Atrial fibrillation General Medicine medicine.disease Atrial septal defects Cardiac surgery Coronary artery disease Internal medicine Pediatrics Perinatology and Child Health medicine Cardiology Radiology Nuclear Medicine and imaging Surgery cardiovascular diseases Cardiology and Cardiovascular Medicine business Tetralogy of Fallot |
| Zdroj: | Congenital Heart Disease. 7:392-399 |
| ISSN: | 1747-079X |
| Popis: | Background. Atrial fibrillation (AF) is a common arrhythmia in adults with congenital heart disease (CHD). Long-term antiarrhythmic therapy (AAT) in these patients has significant shortcomings. The safety and efficacy of pulmonary vein antrum isolation (PVAI) for the treatment of AF in CHD is presently unknown. Hypothesis. We hypothesized that PVAI for AF in patients with CHD is effective and safe. Methods. We reviewed a prospective cohort of 4315 patients (age 18) undergoing PVAI for drug refractory AF at a single institution and identified 36 consecutive patients with CHD (single ventricle physiology, tetralogy of Fallot, coarctation of the aorta, ventricular septal defects, atrial septal defects (ASD) and cardiomyopathy resulting from anomalous origin of the left main coronary from the pulmonary artery). A second cohort of 355 consecutive patients with noncongenital structural heart disease (NSHD) (coronary artery disease, valvular heart disease, ejection fraction |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text